ARCHIVES

Recommendations For Adjuvant Therapy In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Duke Tells ACS The Check for $437,400 Is In The Mail

December 10, 2010

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Also Cancer policy board urges NCI to convene panel on long-term care for childhood cancer survivors.

October 10, 2003

PA Center To Receive Share Of State’s Tobacco Settlement.

September 7, 2001

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990